Molecular Partners AG (MOLN)
5.71
+0.29
(+5.35%)
USD |
NASDAQ |
Nov 22, 09:48
Molecular Partners Shareholders Equity (Quarterly): 164.96M for Sept. 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 164.96M |
| June 30, 2024 | 173.06M |
| March 31, 2024 | 186.80M |
| December 31, 2023 | 210.05M |
| September 30, 2023 | 214.45M |
| June 30, 2023 | 229.05M |
| March 31, 2023 | 243.20M |
| December 31, 2022 | 253.65M |
| September 30, 2022 | 257.84M |
| June 30, 2022 | 278.59M |
| March 31, 2022 | 286.48M |
| December 31, 2021 | 117.37M |
| September 30, 2021 | 133.15M |
| June 30, 2021 | 146.19M |
| December 31, 2020 | 122.72M |
| June 30, 2020 | 32.60M |
| Date | Value |
|---|---|
| December 31, 2019 | 55.88M |
| June 30, 2019 | 79.92M |
| June 30, 2019 | 79.92M |
| December 31, 2018 | 93.14M |
| June 30, 2018 | 116.61M |
| June 30, 2018 | 116.61M |
| December 31, 2017 | 119.83M |
| June 30, 2017 | 123.79M |
| June 30, 2017 | 123.79M |
| December 31, 2016 | 133.45M |
| June 30, 2016 | 144.36M |
| June 30, 2016 | 144.36M |
| December 31, 2015 | 153.57M |
| June 30, 2015 | 154.35M |
| June 30, 2015 | 154.35M |
| December 31, 2014 | 150.16M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
32.60M
Minimum
Jun 2020
286.48M
Maximum
Mar 2022
182.71M
Average
186.80M
Median
Mar 2024
Shareholders Equity (Quarterly) Benchmarks
| AC Immune SA | 154.72M |
| CRISPR Therapeutics AG | 1.940B |
| Addex Therapeutics Ltd | 14.07M |
| NLS Pharmaceutics Ltd | -9.268M |
| MoonLake Immunotherapeutics | 488.20M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 183.31M |
| Total Liabilities (Quarterly) | 18.34M |
| Current Ratio | 14.33 |